Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.